UTI - Lower Urinary Tract Infection

3
Pipeline Programs
1
Companies
1
Clinical Trials
2
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

On Market (2)

Approved therapies currently available

U
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINERApproved
ciprofloxacin
Unknown Company
Fluoroquinolone Antibacterial [EPC]injection2008
U
OTIPRIOApproved
ciprofloxacin
Unknown Company
otic2015

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Iterum Therapeutics
Iterum TherapeuticsDUBLIN 1, Ireland
1 program
1
CiprofloxacinPhase 4Small Molecule1 trial
Active Trials
NCT03366207CompletedEst. Oct 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Iterum TherapeuticsCiprofloxacin

Clinical Trials (1)

NCT03366207Iterum TherapeuticsCiprofloxacin

Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)

Start: Dec 2017Est. completion: Oct 2018
Phase 4Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space